Daniels Pharmaceuticals, Inc. – Trademark Portfolio
Entity Type: 03
Daniels Pharmaceuticals, Inc. holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 16 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include DP, UROEZE, LEVOXYL, TUMIL-K, and TUSSIGON. The owner is based in St. Petersburg, FL.
2527 25th Avenue North
St. Petersburg, FL 33713
Showing of trademarks Trademarks
Trademark Classifications
Daniels Pharmaceuticals, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Daniels Pharmaceuticals, Inc. have?
Daniels Pharmaceuticals, Inc. has 18 U.S. trademarks filed with the USPTO. Of these, 6 registered, 3 abandoned, 9 cancelled.
What trademark classes does Daniels Pharmaceuticals, Inc. file in?
Daniels Pharmaceuticals, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Daniels Pharmaceuticals, Inc.'s most well-known trademarks?
Daniels Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as DP, UROEZE, LEVOXYL, TUMIL-K, and TUSSIGON. These are among 6 currently registered trademarks in the portfolio.
What is Daniels Pharmaceuticals, Inc.'s trademark registration success rate?
Daniels Pharmaceuticals, Inc. has a 33% trademark registration rate, with 6 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.